Evidence map›Paper›PMID 28611516›Full record

ReviewWorld journal of gastroenterology2017

Colorectal cancer population screening programs worldwide in 2016: An update.

Mercedes Navarro, Andrea Nicolas, Angel Ferrandez, Angel Lanas

Abstract readReview
In one paragraph

Review in World journal of gastroenterology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 285 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
285citing papers in PubMed, 12 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

285 citing papers in PubMed, 12 syntheses or guidelines pooled it.

  1. Geographical Disparities in Faecal Immunochemical Test-Based Colorectal Cancer Screening Participation and Positivity Rates: A Systematic Review and Meta-Analysis.Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Trial
  14. Blood Test Increases Colorectal Cancer Screening in Persons Who Declined Colonoscopy and Fecal Immunochemical Test: A Randomized Controlled Trial.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023
    Trial
  15. Trial
  16. Article
  17. Article
  18. Flexible IMU Sensor Array For 3D Colonoscope Shape Reconstruction and AI-Based Loop Detection.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  19. Article
  20. Article

225 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mercedes NavarroMercedes Navarro, Angel Ferrandez, Angel Lanas, Service of Digestive Diseases, University Clinic Hospital Lozano Blesa, Avenida San Juan Bosco, Zaragoza 50009, Spain.
Andrea NicolasMercedes Navarro, Angel Ferrandez, Angel Lanas, Service of Digestive Diseases, University Clinic Hospital Lozano Blesa, Avenida San Juan Bosco, Zaragoza 50009, Spain.
Angel FerrandezMercedes Navarro, Angel Ferrandez, Angel Lanas, Service of Digestive Diseases, University Clinic Hospital Lozano Blesa, Avenida San Juan Bosco, Zaragoza 50009, Spain.
Angel LanasMercedes Navarro, Angel Ferrandez, Angel Lanas, Service of Digestive Diseases, University Clinic Hospital Lozano Blesa, Avenida San Juan Bosco, Zaragoza 50009, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is the third most commonly diagnosed cancer in the world. The incidence and mortality show wide geographical variations. Screening is recommended to reduce both incidence and mortality. However, there are significant differences among studies in implementation strategies and detection. This review aimed to present the results and strategies of different screening programs worldwide. We reviewed the literature on national and international screening programs published in PubMed, on web pages, and in clinical guidelines. CRC Screening programs are currently underway in most European countries, Canada, specific regions in North and South America, Asia, and Oceania. The most extensive screening strategies were based on fecal occult blood testing, and more recently, the fecal immunochemical test (FIT). Participation in screening has varied greatly among different programs. The Netherlands showed the highest participation rate (68.2%) and some areas of Canada showed the lowest (16%). Participation rates were highest among women and in programs that used the FIT test. Men exhibited the greatest number of positive results. The FIT test has been the most widely used screening program worldwide. The advent of this test has increased participation rates and the detection of positive results.

Indexed as

ColonoscopyAdultAgedCanadaColorectal NeoplasmsEarly Detection of CancerFecesFemaleGeographyGlobal HealthHumansImmunochemistryIncidenceMaleMass ScreeningMiddle AgedColonoscopyColorectal cancerColorectal cancer screeningFecal immunochemical testFecal occult blood test

Identifiers

PMID28611516
PMCPMC5449420

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.